Souad Assaad

754 total citations
20 papers, 277 citations indexed

About

Souad Assaad is a scholar working on Oncology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Souad Assaad has authored 20 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Infectious Diseases and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Souad Assaad's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer survivorship and care (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Souad Assaad is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer survivorship and care (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Souad Assaad collaborates with scholars based in France, Switzerland and Canada. Souad Assaad's co-authors include Christopher R.W. Edwards, S C Low, Jonathan R. Seckl, Karen E. Chapman, Valanila P. Rajan, Emmanuel Disse, Gérald Raverot, Stéphane Dalle, Françoise Borson‐Chazot and Jean‐Yves Blay and has published in prestigious journals such as Blood, Gut and The Lancet Oncology.

In The Last Decade

Souad Assaad

16 papers receiving 273 citations

Peers

Countries citing papers authored by Souad Assaad

Since Specialization

Citations

This map shows the geographic impact of Souad Assaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Souad Assaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Souad Assaad more than expected).

Fields of papers citing papers by Souad Assaad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Souad Assaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Souad Assaad. The network helps show where Souad Assaad may publish in the future.

Co-authorship network of co-authors of Souad Assaad

This figure shows the co-authorship network connecting the top 25 collaborators of Souad Assaad. A scholar is included among the top collaborators of Souad Assaad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Souad Assaad. Souad Assaad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers 2025 ·ESMO Open ·Jean‐Yves Blay, (unknown), Armelle Dufresne, (unknown), Virginie Avrillon, Souad Assaad, C. Decroisette, Bénédicte Mastroïanni, (unknown), (unknown), (unknown), Pierre Méeus, Aurélie Dutour, Marie Castets, M. Pérol, Pierre-Étienne Heudel	0
2	Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study 2025 ·Frontiers in Medicine ·(unknown), Olivia Pérol, (unknown), Marvin Borja, (unknown), Stéphane Morisset, Anne‐Sophie Michallet, Aude Fléchon, Helen Boyle, Emmanuelle Nicolas‐Virelizier, (unknown), (unknown), Souad Assaad, Amine Belhabri, Laure Lebras, Jean‐Yves Blay, Béatrice Fervers, Mauricette Michallet	0
3	Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia 2024 ·Annals of Hematology ·Cécile Tomowiak, Stéphanie Poulain, (unknown), Pierre Feugier, Charles Herbaux, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, (unknown), Damien Roos‐Weil, José Miguel Torregrosa Diaz, Sylvie Chevret, Véronique Leblond, (unknown)	2
4	Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study 2024 ·European Journal of Cancer ·(unknown), Souad Assaad, Lidia Delrieu, Bertrand Favier, Élise Dumas, Anne‐Sophie Hamy, Aurélien Latouche, (unknown), Jean‐Yves Blay, Jimmy Mullaert, Annabelle Ballesta, Pierre-Étienne Heudel	16
5	Gastric signet-ring cell adenocarcinoma masquerading as sarcoidosis 2024 ·The Lancet Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Souad Assaad, Mona Amini‐Adlé	0
6	846P Artificial intelligence-driven identification of onco-hematology patients who may develop severe COVID-19 2023 ·Annals of Oncology ·Souad Assaad, Jean‐Yves Blay, (unknown), Pierre-Étienne Heudel, Samir Bouam, (unknown), Guillaume Chassagnon, Camille Bigenwald, Laurence Albigès, Fabrice André, Enzo Battistella, Olivier Teboul, (unknown), (unknown), (unknown), Walid Kandeil, (unknown), (unknown), (unknown), Nikos Paragios	1
7	Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions 2023 ·Clinical Pharmacokinetics ·C. Grangé, Catherine Rioufol, Pierre-Jean Souquet, Souad Assaad	1
8	Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients 2022 ·European Journal of Cancer ·Pierre-Étienne Heudel, Bertrand Favier, (unknown), Souad Assaad, (unknown), Olivier Trédan, Thomas Bachelot, I. L. Ray-Coquard, (unknown), (unknown), Bénédicte Mastroïanni, Virginie Avrillon, Anne‐Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol, Jean‐Yves Blay	13
9	Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review) 2021 ·Cancers ·(unknown), Christine Cugnet‐Anceau, Stéphane Dalle, Karim Chikh, Souad Assaad, Emmanuel Disse, Gérald Raverot, Françoise Borson‐Chazot, (unknown)	23
10	Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia 2021 ·Blood Advances ·Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, (unknown), Damien Roos‐Weil, Sylvie Chevret, Véronique Leblond	21
11	Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study 2021 ·British Journal of Cancer ·Souad Assaad, Philippe Zrounba, Claire Cropet, Jean‐Yves Blay	17
12	Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial 2021 ·BMJ Open ·(unknown), Emmanuelle Nicolas‐Virelizier, Chiara Russo, Olivia Pérol, Guillaume Y. Millet, (unknown), Lidia Delrieu, Anne‐Sophie Michallet, Souad Assaad, Amine Belhabri, Lila Gilis, (unknown), Laure Lebras, (unknown), (unknown), (unknown), C. Terret, Mauricette Michallet, Béatrice Fervers	1
13	Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up 2020 ·Journal of Clinical Medicine ·(unknown), J. Abeillon, Stéphane Dalle, Souad Assaad, Françoise Borson‐Chazot, Emmanuel Disse, Gérald Raverot, Christine Cugnet‐Anceau	24
14	Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study 2019 ·Blood ·Mauricette Michallet, Mohamad Sobh, (unknown), (unknown), (unknown), Emmanuelle Nicolas‐Virelizier, Souad Assaad, Amine Belhabri, Laure Lebras, (unknown), (unknown), Lila Gilis, Franck E. Nicolini, Stéphane Morisset, (unknown), Gisèle Chvetzoff, Jean‐Yves Blay, Béatrice Fervers, Anne‐Sophie Michallet	1
15	18F-FDG PET/CT as a central tool in the shift from chronic Q fever to Coxiella burnetii persistent focalized infection 2016 ·Medicine ·Carole Eldin, Cléa Melenotte, Matthieu Million, Serge Cammilleri, Albert Sotto, (unknown), Franck Thuny, Hubert Lépidi, F. Roblot, Thierry Weitten, Souad Assaad, (unknown), C. Chapuzet, Guillaume Gras, (unknown), C. Landais, Pascale Longuet, A. Masseau, O. Mundler, Didier Raoult	37
16	A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease 2015 ·Gut ·Gilles Boschetti, Souad Assaad, B. Balme, Sylvie Boyer, Bernard Flourié, Stéphane Nancey	5
17	Wire brushing wood furniture, granulomatosis and microscopic mineralogical analysis. 2014 ·PubMed ·Mickaël Catinon, C. Chemarin, Souad Assaad, (unknown), (unknown), Alexandra Traverse‐Glehen, Catherine Cavalin, Paul‐André Rosental, Michel Vincent	4
18	Ischémie digitale après injection d’un comprimé pilé de zolpidem, amélioration tardive par l’iloprost 2008 ·Therapies ·Alexandra Boucher, Souad Assaad, (unknown), Jacques Descotes	7
19	La tuberculose intestinale : une forme méconnue d’une infection trop connue 2008 ·Médecine et Maladies Infectieuses ·Cécile Nozières, (unknown), Souad Assaad, (unknown)	1
20	Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney 1993 ·Journal of Endocrinology ·S C Low, Souad Assaad, Valanila P. Rajan, Karen E. Chapman, Christopher R.W. Edwards, Jonathan R. Seckl	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact